Clinical Trials in Atlanta

Showing 2941-2960 of 9,468 trials

Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

NCT05161078

To date, little knowledge exists related to the use of hemodialysis (HD) in infants and has been limited to mainly single center studies. The CARPEDIEM (CArdio-Renal PEdiatric Dialysis Emergency Machine) device, which can be used to provide hemodialysis in infants, has been launched in the United States. This study/registry is designed to obtain data on critically ill infants who require HD using the CARPEDIEM device to understand the indications for initiation, best practice in prescribing and performing treatment, expected treatment course, and outcomes of a dedicated infant continuous renal replacement therapy (CRRT) machine.

Acute Kidney InjuryChronic Kidney DiseasesRenal Dialysis

Children's Hospital Medical Center, Cincinnati1,000 participantsStarted Dec 2021

Palo Alto, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +6 more locations

TERMINATEDPhase 2< 1 mile

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

NCT01032070

This is a phase 2 study to evaluate the efficacy of single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma.

Recurrent or Refractory Pediatric Ependymoma

OSI Pharmaceuticals25 participantsStarted Sep 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Orange, California, United States +25 more locations

Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Find Trials by Condition in Atlanta

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Study of ATH434 in Participants with Multiple System Atrophy

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

A Drug-drug Interaction Study of Avapritinib and Midazolam

Osia 2 Pediatric Expansion Study

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies